BCR Antikörper (AA 144-193)
Kurzübersicht für BCR Antikörper (AA 144-193) (ABIN2888957)
Target
Alle BCR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 144-193
-
Spezifität
- Bcr (Ab-177) Antibody detects endogenous levels of total Bcr protein.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human Bcr (aa144-193).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: Peptide-ELISA (1:20000), WB (1:500 - 1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- BCR (Breakpoint Cluster Region (BCR))
-
Andere Bezeichnung
- CML / BCR
-
Hintergrund
-
Name/Gene ID: BCR
Subfamily: BCR
Family: Protein Kinase
Synonyms: BCR, Acute lymphocytic leukemia, ALL, BCR1, BCR/FGFR1 chimera protein, Breakpoint cluster region, Chronic myeloid leukemia, D22S11, CML, D22S662, Philadelphia chromosome, PHL, FGFR1/BCR chimera protein -
Gen-ID
- 613
-
UniProt
- P11274
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
Target
-